Bayer sells division to Boston Scientific

SHARE Bayer sells division to Boston Scientific

BERLIN (AP) — Germany’s Bayer AG says it’s selling its interventional division to the Boston Scientific Corp. for $415 million so that it can focus on growth in other areas.

The Leverkusen-based company said Thursday the sale includes its AngioJet system used to remove blood clots, its Jetstream system for arterial disease treatment, and the Fetch 2 Aspiration Catheter used in cardiology, radiology and peripheral vascular procedures.

Bayer says the sale will allow its HealthCare unit to focus more on growing its radiology and diabetes care business segments.

Natick, Massachusetts-based Boston Scientific says the acquisition is expected to expand the company’s access to customers in need of such treatments.

The transaction is subject to antitrust approval and is expected to clear in the second half of 2014.

Bayer to buy Merck consumer business for $14.2B

Abbott may sell off older drugs

Merck makes deal worth at least $600M with Santen

Akorn plans $440M acquisition of VersaPharm

The Latest
Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.
The art of goaltending has changed significantly since Robb Stauber’s aggressive career in the 1990s. But the mindset of goaltending hasn’t, and Jaxson has followed the same approach to experience immediate NHL success.
The child’s horrified grandmother refuses to use the name and refers to the girl only as ‘little one.’
The report by the Civic Committee of the Commercial Club of Chicago is a new message from a group that opposed Gov. J.B. Pritzker on the graduated income tax in 2020.
Video clips show bright young people surrendering themselves to Larry Ray’s brainwashing techniques and psychological and physical abuse.